Published Date: 02 Mar 2023
Influenza vaccination during the 2022-2023 season is recommended for the treatment of fever in children and adults under 65 years of age, flu symptoms in children, . ..
Read Full NewsTake 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 6, 2026.
A new comparison study of patients with autoimmune diseases reported high rates of anxiety and depression, with notable differences in when psychiatric symptoms emerged relative to disease onset.
A real-world study showed that cladribine tablets were associated with greater treatment persistence and lower health care costs in patients with multiple sclerosis compared with other common therapies.
The single-arm CLAD-MAPET study is evaluating whether cladribine tablets reduce microglial activation, captured by [F-18]PBR06-PET, in patients with MS experiencing progression without relapse or MRI activity on anti-CD20 therapy.
Delay Discounting Fails to Predict MDD Relapse, Q&A With Giles Story, PhD
The HCPFive: Top News for Healthcare Providers from the Week of 02/01
HCPLive 5 Stories in Under 5: Week of 02/01
1.
Hybrid imaging test combines antibody and radioisotope for early lung cancer detection
2.
Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.
3.
Elder Abuse: Red Flags to Look Out For While Receiving Care.
4.
Pancreatic cancer RNA vaccine shows durable T cell immunity
5.
Dietary Intervention Shows Promise in Blood Cancers
1.
The Bloodstream Compass: A Comparative Clinical Review of Liquid Biopsy and AI in Predictive Oncology
2.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
3.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
4.
The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects
5.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
3.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
4.
Navigating the Complexities of Ph Negative ALL - Part III
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation